BioCryst Pharmaceuticals
BCRX
#4539
Rank
S$3.22 B
Marketcap
S$12.71
Share price
1.97%
Change (1 day)
11.56%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Net assets

Net assets on the balance sheet as of March 2026 : -S$0.72 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has -S$0.72 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioCryst Pharmaceuticals - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-S$0.16 Billion-76.35%
2024-12-31$-S$0.65 Billion7.53%
2023-12-31$-S$0.61 Billion52.33%
2022-12-31$-S$0.4 Billion173.06%
2021-12-31$-S$0.15 Billion467.59%
2020-12-31$-S$25.49 Million-149.41%
2019-12-31$S$51.57 M-23.33%
2018-12-31$S$67.26 M-39.96%
2017-12-31$S$0.11 B4805.7%
2016-12-31$S$2.28 M-96.62%
2015-12-31$S$67.5 M-32.45%
2014-12-31$S$99.93 M-7105.34%
2013-12-31$-S$1.43 Million156.96%
2012-12-31$-S$0.56 Million-102.9%
2011-12-31$S$19.17 M-77.27%
2010-12-31$S$84.37 M-30.33%
2009-12-31$S$0.12 B82.41%
2008-12-31$S$66.39 M-28.91%
2007-12-31$S$93.39 M187.92%
2006-12-31$S$32.43 M-66.66%
2005-12-31$S$97.3 M103.33%
2004-12-31$S$47.85 M-0.98%
2003-12-31$S$48.33 M-30.59%
2002-12-31$S$69.62 M-33.8%
2001-12-31$S$0.10 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
S$30.25 B-4,330.62%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$29.79 B-4,265.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S$1.94 B-371.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$2.71 B-480.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-S$0.19 Billion-73.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.58 B-182.37%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S$9.26 M-101.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S$20.6 M-102.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.75 B-205.17%๐Ÿ‡บ๐Ÿ‡ธ USA